Shireman, J. M., Atashi, F., Lee, G., Ali, E. S., Saathoff, M. R., Park, C. H., . . . Ahmed, A. U. (2021). De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain.
Chicago-стиль цитированияShireman, Jack M., et al. "De Novo Purine Biosynthesis Is a Major Driver of Chemoresistance in Glioblastoma." Brain 2021.
MLA-цитированиеShireman, Jack M., et al. "De Novo Purine Biosynthesis Is a Major Driver of Chemoresistance in Glioblastoma." Brain 2021.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.